NanoString Technologies Inc (NSTG)

13.64
0.03 0.22
NASDAQ : Health Care
Prev Close 13.67
Open 13.61
Day Low/High 13.35 / 13.91
52 Wk Low/High 11.30 / 19.81
Volume 108.05K
Avg Volume 125.30K
Exchange NASDAQ
Shares Outstanding 19.77M
Market Cap 263.57M
EPS -2.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Oversold Conditions For NanoString Technologies (NSTG)

Oversold Conditions For NanoString Technologies (NSTG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NanoString Technologies Releases Operating Results For First Quarter Of 2016

NanoString Technologies Releases Operating Results For First Quarter Of 2016

Revenue Growth Driven by Strong Consumable Pull-Through and Diagnostic Collaborations

NanoString Technologies Presents Proof-of-Concept Data For Multiplexed Digital IHC In Tumor Tissues At AACR Meeting

NanoString Technologies Presents Proof-of-Concept Data For Multiplexed Digital IHC In Tumor Tissues At AACR Meeting

nCounter-Based Technology Counts Protein Targets in the Spatial Context of Fixed, Slide-Mounted Tissues

Providence Health & Services And Institute For Systems Biology Affiliate To Catalyze Scientific Wellness

Providence Health & Services And Institute For Systems Biology Affiliate To Catalyze Scientific Wellness

Dr. Leroy Hood to serve as chief science officer for Providence

NanoString Technologies Releases Fourth Quarter And Full Year 2015 Financial Results and Provides 2016 Outlook

NanoString Technologies Releases Fourth Quarter And Full Year 2015 Financial Results and Provides 2016 Outlook

Record Revenue Driven by Installed Base Growth, Robust Consumable Pull-Through and Multiple Companion Diagnostic Collaborations

NanoString Technologies And Merck Expand Collaboration To Develop And Commercialize Novel Diagnostic Test To Predict Response To KEYTRUDA® (pembrolizumab)

NanoString Technologies And Merck Expand Collaboration To Develop And Commercialize Novel Diagnostic Test To Predict Response To KEYTRUDA® (pembrolizumab)

NanoString Eligible to Receive Up to $24 Million for Technology Access and Near-Term Milestones, Plus Development Funding and Undisclosed Downstream Payments

NanoString Technologies Presents Proof-of-Concept Data For Novel Massively Parallel Single Molecule Sequencing Chemistry At AGBT Meeting

NanoString Technologies Presents Proof-of-Concept Data For Novel Massively Parallel Single Molecule Sequencing Chemistry At AGBT Meeting

Hyb & Seq™ Chemistry Demonstrates High Accuracy With Simple Workflow Free of Library, Enzymes and Amplification

American Society Of Clinical Oncology (ASCO) Clinical Practice Guideline Recommends Use Of Prosigna (PAM50) For Guiding Treatment Decisions In Early Stage Breast Cancer Patients

American Society Of Clinical Oncology (ASCO) Clinical Practice Guideline Recommends Use Of Prosigna (PAM50) For Guiding Treatment Decisions In Early Stage Breast Cancer Patients

Prosigna One of Only Two Assays to Receive Strong Recommendation Together With High Rating of Evidence Quality

NanoString Technologies Provides Preliminary Operational And Financial Results For 2015

NanoString Technologies Provides Preliminary Operational And Financial Results For 2015

Expected Full Year 2015 Revenue Growth of 29% to 31% Year Over Year

NanoString Technologies Becomes Oversold (NSTG)

NanoString Technologies Becomes Oversold (NSTG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NanoString Technologies Expands 3D Biology Portfolio With The Commercial Launch Of Seven New NCounter PanCancer Profiles To Deeply Probe Cancer Biology

NanoString Technologies Expands 3D Biology Portfolio With The Commercial Launch Of Seven New NCounter PanCancer Profiles To Deeply Probe Cancer Biology

Focused Gene Expression Panels Are Designed to Combine With Protein Expression Modules and Target Seven Key Aspects of Cancer Biology Including Immuno-Oncology

RSI Alert: NanoString Technologies (NSTG) Now Oversold

RSI Alert: NanoString Technologies (NSTG) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.